
SolaFire
SolaFire appears to be unavailable at this time.

AI-driven drug discovery for metabolic and age-related diseases using human longitudinal data.

BioAge Labs operates a clinical-stage biotechnology architecture that leverages artificial intelligence to map the molecular pathways of human aging. The core technical advantage lies in their proprietary platform that integrates massive longitudinal datasets—some spanning over 50 years of human health tracking. By applying machine learning to deep proteomic and metabolomic profiles, the platform identifies specific proteins and pathways that correlate with healthy aging or disease resistance. In 2026, BioAge is positioned as a leader in 'Targeted Longevity,' transitioning from speculative science to data-driven clinical validation. Their AI engine identifies novel drug targets which are then progressed through in-house clinical pipelines, most notably in the metabolic space (e.g., Azelaprag). The architecture differs from generative chemistry models by prioritizing 'human-first' evidence, ensuring that targets identified have already demonstrated biological significance in real-world human cohorts before laboratory synthesis begins. This reduces the high failure rate typically associated with preclinical animal models.
BioAge Labs operates a clinical-stage biotechnology architecture that leverages artificial intelligence to map the molecular pathways of human aging.
Explore all tools that specialize in discover biomarkers. This domain focus ensures BioAge Labs AI Platform delivers optimized results for this specific requirement.
Explore all tools that specialize in proteomic analysis. This domain focus ensures BioAge Labs AI Platform delivers optimized results for this specific requirement.
Explore all tools that specialize in analyze biomarkers related to aging. This domain focus ensures BioAge Labs AI Platform delivers optimized results for this specific requirement.
A proprietary ML model trained on 50+ years of human bio-samples to identify drivers of metabolic health.
Mass-spectrometry based data processing that identifies thousands of proteins in a single sample to find disease signatures.
Graph-based neural networks used to map biological pathways and identify druggable nodes.
AI-optimized agonist development for the apelin receptor to treat muscle atrophy.
Machine learning algorithms that predict which patients will respond best to specific anti-aging therapies.
Real-time analysis of metabolic byproducts to assess biological age vs. chronological age.
Deep learning models that simulate the effect of new compounds on healthy human cellular pathways.
Submission of partnership inquiry and initial therapeutic alignment.
Execution of Mutual Non-Disclosure Agreement (mNDA).
Technical audit of shared longitudinal datasets or biobank access requirements.
Integration with BioAge's proprietary data ingestion pipeline.
Initialization of AI-driven target discovery phase for specific disease indicators.
Review of proteomic and metabolomic correlation maps generated by the engine.
Validation of identified targets through in vitro and in vivo assays.
Selection of lead candidate molecules or clinical-stage assets.
Joint clinical development planning and regulatory strategy formulation.
Full deployment of clinical trial monitoring and patient stratification tools.
All Set
Ready to go
Verified feedback from other users.
"Highly regarded in the biotech industry for their data-first approach and successful clinical progression of assets."
Post questions, share tips, and help other users.

SolaFire appears to be unavailable at this time.

Decoding biology to radically improve lives through AI-powered drug discovery.

A free, open-source application for creating behavioral experiments.

The Protein Engineering Operating System for targeting the undruggable proteome.

Open Access publisher of peer-reviewed research in biological, medical and environmental sciences.

The premier multi-omics discovery index for cross-repository data orchestration and meta-analysis.

Leveraging the Ubiquitin-Proteasome System to Modulate the Undruggable Proteome

Accelerating the discovery of life-changing bioactive peptides through AI-driven molecular intelligence.